MiPBF
Pharmaceutical compound
From Wikipedia, the free encyclopedia
MiPBF, also known as N-methyl-N-isopropyl-3-(2-aminoethyl)benzofuran or as 1-oxa-N-methyl-N-isopropyltryptamine (1-oxa-MiPT), is a serotonin receptor modulator of the benzofuran family related to the psychedelic tryptamine methylisopropyltryptamine (MiPT).[1][2] It is the analogue and bioisostere of MiPT in which the indole nitrogen has been replaced with an oxygen atom, making it a benzofuran rather than tryptamine derivative.[1][2] The drug shows affinity for serotonin receptors, including the serotonin 5-HT1A, 5-HT2A, and 5-HT2B receptors (IC50 = 5,000 nM, 500 nM, and 800 nM, respectively).[1][2] Its affinities for these receptors were 7-fold, 13-fold, and 1.5-fold lower than those of MiPT, respectively.[1][2] MiPBF was first described in the scientific literature by Dennis McKenna and David Repke and colleagues in 1990.[1][2]
- None
| Clinical data | |
|---|---|
| Other names | Methylisopropylbenzofuran; MIPBF; N-Methyl-N-isopropyl-3-(2-aminoethyl)benzofuran; 1-Oxa-N-methyl-N-isopropyltryptamine; 1-Oxa-MiPT |
| Drug class | Serotonin receptor modulator |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C14H19NO |
| Molar mass | 217.312 g·mol−1 |
| 3D model (JSmol) | |
| |
| |